Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
AstraZeneca
Covington
Mallinckrodt
US Department of Justice
Cerilliant
Cantor Fitzgerald
Harvard Business School
Citi

Generated: April 24, 2018

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR FOSAPREPITANT DIMEGLUMINE

« Back to Dashboard

Clinical Trials for FOSAPREPITANT DIMEGLUMINE

Trial ID Title Status Sponsor Phase Summary
NCT00004936 MRI and CT Scans to Evaluate Invasive Cervical Cancer Before Treating Patients Completed National Cancer Institute (NCI) N/A RATIONALE: Imaging procedures such as MRI or CT scans may improve the ability to detect cervical cancer and determine the extent of disease. PURPOSE: Diagnostic trial to determine the effectiveness of MRI and CT scans in evaluating invasive cervical cancer before treatment of patients.
NCT00004936 MRI and CT Scans to Evaluate Invasive Cervical Cancer Before Treating Patients Completed American College of Radiology Imaging Network N/A RATIONALE: Imaging procedures such as MRI or CT scans may improve the ability to detect cervical cancer and determine the extent of disease. PURPOSE: Diagnostic trial to determine the effectiveness of MRI and CT scans in evaluating invasive cervical cancer before treatment of patients.
NCT00033397 Diagnostic Procedures in Women With Locally Advanced Breast Cancer Who Are Receiving Chemotherapy Before Breast Cancer Surgery Active, not recruiting National Cancer Institute (NCI) N/A RATIONALE: Comparing results of diagnostic procedures performed before, during, and after chemotherapy may help doctors predict a patient's response to treatment and help plan the most effective treatment. PURPOSE: Diagnostic trial to study magnetic resonance imaging (MRI) and biomarkers in women who are receiving chemotherapy before surgery for locally advanced breast cancer.
NCT00033397 Diagnostic Procedures in Women With Locally Advanced Breast Cancer Who Are Receiving Chemotherapy Before Breast Cancer Surgery Active, not recruiting Alliance for Clinical Trials in Oncology N/A RATIONALE: Comparing results of diagnostic procedures performed before, during, and after chemotherapy may help doctors predict a patient's response to treatment and help plan the most effective treatment. PURPOSE: Diagnostic trial to study magnetic resonance imaging (MRI) and biomarkers in women who are receiving chemotherapy before surgery for locally advanced breast cancer.
Trial ID Title Status Sponsor Phase Summary

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Clinical Trial Conditions for FOSAPREPITANT DIMEGLUMINE

Condition Name

Condition Name for FOSAPREPITANT DIMEGLUMINE
Intervention Trials
Chemotherapy-Induced Nausea and Vomiting 9
Nausea 4
Vomiting 4
Chemotherapy-Induced Nausea and Vomiting (CINV) 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for FOSAPREPITANT DIMEGLUMINE
Intervention Trials
Vomiting 21
Nausea 13
Carcinoma 3
Sarcoma 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for FOSAPREPITANT DIMEGLUMINE

Trials by Country

Trials by Country for FOSAPREPITANT DIMEGLUMINE
Location Trials
United States 39
Japan 4
Denmark 1
China 1
Australia 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for FOSAPREPITANT DIMEGLUMINE
Location Trials
California 8
New York 4
North Carolina 3
Missouri 2
Indiana 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for FOSAPREPITANT DIMEGLUMINE

Clinical Trial Phase

Clinical Trial Phase for FOSAPREPITANT DIMEGLUMINE
Clinical Trial Phase Trials
Phase 4 4
Phase 3 7
Phase 2 10
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for FOSAPREPITANT DIMEGLUMINE
Clinical Trial Phase Trials
Completed 17
Terminated 6
Active, not recruiting 4
[disabled in preview] 4
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for FOSAPREPITANT DIMEGLUMINE

Sponsor Name

Sponsor Name for FOSAPREPITANT DIMEGLUMINE
Sponsor Trials
Merck Sharp & Dohme Corp. 13
National Cancer Institute (NCI) 7
University of Southern California 2
[disabled in preview] 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for FOSAPREPITANT DIMEGLUMINE
Sponsor Trials
Other 33
Industry 20
NIH 7
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Citi
Johnson and Johnson
Teva
Queensland Health
Deloitte
Express Scripts
Baxter
Julphar
US Department of Justice

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.